Company Overview

AQUESTIVE THERAPEUTICS, INC.

AQST
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
45M
2025 FY
Net Income
-84M
2025 FY
Shares Outstanding
107M
2025 FY
EPS
-0.78USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1398733
Exchange
Nasdaq
Location
US